|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
A Randomized, Participant- and Investigator-blinded, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
The purpose of this study is to characterize the effect on dengue viral load, fever clearance time as well as on clinical signs and symptoms with the treatment of EYU688 compared with placebo in patients with dengue fever.
A randomized, participant- and investigator-blinded, placebo-controlled, parallel group study to assess the efficacy, safety and pharmacokinetics of EYU688 in patients with dengue fever - NIL
100 Clinical Results associated with NS4B x SSTR
100 Translational Medicine associated with NS4B x SSTR
0 Patents (Medical) associated with NS4B x SSTR